Overview

Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Characterize the demographic and clinical features, as well as the main treatment results, among patients with advanced breast cancer treated with fulvestrant in Brazil.
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Dendrix - Scientific Information Architecture
Treatments:
Estradiol
Fulvestrant